ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 272 filers reported holding ALKERMES PLC in Q2 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,165 | +5.6% | 16,143 | +18.0% | 0.00% | 0.0% |
| Q2 2023 | $428,153 | +9.7% | 13,679 | -1.2% | 0.00% | 0.0% |
| Q1 2023 | $390,234 | +10.5% | 13,843 | +2.5% | 0.00% | 0.0% |
| Q4 2022 | $353,042 | -51.6% | 13,511 | -58.6% | 0.00% | -50.0% |
| Q3 2022 | $729,000 | +1.0% | 32,644 | +34.6% | 0.00% | 0.0% |
| Q2 2022 | $722,000 | -2.2% | 24,250 | -13.6% | 0.00% | +100.0% |
| Q1 2022 | $738,000 | -22.1% | 28,068 | -31.0% | 0.00% | 0.0% |
| Q4 2021 | $947,000 | +95.7% | 40,704 | +159.4% | 0.00% | 0.0% |
| Q3 2021 | $484,000 | – | 15,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |